Abstract:The latest advances in activable near‐infrared aggregation‐induced emission luminogens for disease diagnosis and treatment are outlined according to various internal stimuli, including enzymes, reactive oxygen species, gases, ions, viscosity, hypoxia, glutathione, and pH. Each section provides representative examples and highlights the underlying design mechanisms. Finally, the current challenges and future prospects are discussed in depth. As a modality of optical imaging, fluorescence imaging of biochemical analytes holds significant potential in the field of disease diagnosis and therapy. However, the non‐responsive fluorophores are not able to selectively and sensitively detect lesions, resulting in a poor signal‐to‐background ratio and compromised accuracy. The utilization of activatable sensors, in contrast, is capable of effectively overcoming these limitations by displaying variations in fluorescence intensity and spectral wavelength in response to physiological parameters. Aggregation‐induced emission luminogens (AIEgens), particularly those emitting fluorescence in the near‐infrared (NIR, 700–1700 nm) window, have practical application prospects in disease theranostics due to their excellent photostability, deeper penetration depth, and enhanced fluorescence intensity in physiological environments. In this review, an overview of the advancements in research on NIR AIEgens for internal stimuli‐activated diagnosis and treatment of diseases is provided. The design principles of responsive NIR AIEgens and their biomedical applications are exemplified with representative examples, categorized based on the type of stimuli. Finally, the review concludes with a brief discussion of the challenges, opportunities, and future prospects of activatable NIR AIEgens in the field of disease photo theranostics.

NIR‐II AIEgens for Infectious Diseases Phototheranostics

NIR-II Aggregation-Induced Emission Luminogens for Tumor Phototheranostics

NIR-II Phototherapy Agents with Aggregation-Induced Emission Characteristics for Tumor Imaging and Therapy.

NIR-II emissive multifunctional AIEgen with single laser-activated synergistic photodynamic/photothermal therapy of cancers and pathogens

Aggregation‐induced Emission Luminogens for in Vivo Molecular Imaging and Theranostics in Cancer

Aggregation-Induced Emission-Based Platforms for the Treatment of Bacteria, Fungi, and Viruses

Tumor-microenvironment activated second near-infrared agents for tumor imaging and therapy

Aggregation‐Induced Emission‐Based Platforms for the Treatment of Bacteria, Fungi, and Viruses

Aggregation‐Induced Emission Nanoprobes Working in the NIR‐II Region: From Material Design to Fluorescence Imaging and Phototherapy

A New Theranostic Platform Against Gram-Positive Bacteria Based on Near-Infrared-Emissive Aggregation-Induced Emission Nanoparticles

Near‐Infrared‐II Nanomaterials for Activatable Photodiagnosis and Phototherapy

A NIR-II emissive polymer AIEgen for imaging-guided photothermal elimination of bacterial infection

Aggregation-Induced Emission Nanoparticles for Single Near-Infrared Light-Triggered Photodynamic and Photothermal Antibacterial Therapy

Zwitterionic AIEgens: Rational Molecular Design for NIR‐II Fluorescence Imaging‐Guided Synergistic Phototherapy

Recent advances in near-infrared II imaging technology for biological detection

AIEgen-Based Nanomaterials for Bacterial Imaging and Antimicrobial Applications: Recent Advances and Perspectives

Aggregation-induced emission biomaterials for anti-pathogen medical applications: detecting, imaging and killing.

Progress of NIR-II fluorescence imaging technology applied to disease diagnosis and treatment

Near‐Infrared‐II Nanomaterials for Fluorescence Imaging and Photodynamic Therapy

Recent Advances in Small Molecule Dye-Based Nanotheranostics for NIR-II Photoacoustic Imaging-Guided Cancer Therapy

The Midas Touch by Internal Stimuli: Activatable Luminogens with Near‐Infrared Aggregation‐Induced Emission for Potent Bioimaging and Theranostics